Sort   by:  
 Page size 
UnknownWithdrawal of mechanical ventilation in amyotrophic lateral sclerosis patients: a multicenter Italian survey.
Not available
S-EPMC10641048 | biostudies-literature
UnknownErythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study.
Not available
S-EPMC4515982 | biostudies-literature
UnknownOlaparib monotherapy in patients with advanced cancer and a germline BRCA1/2 mutation.
Not available
S-EPMC6057749 | biostudies-literature
UnknownG-CSF (filgrastim) treatment for amyotrophic lateral sclerosis: protocol for a phase II randomised, double-blind, placebo-controlled, parallel group, multicentre clinical study (STEMALS-II trial).
Not available
S-EPMC7202695 | biostudies-literature
UnknownRapamycin treatment for amyotrophic lateral sclerosis: Protocol for a phase II randomized, double-blind, placebo-controlled, multicenter, clinical trial (RAP-ALS trial).
Not available
S-EPMC6024184 | biostudies-literature
UnknownProtein misfolding, amyotrophic lateral sclerosis and guanabenz: protocol for a phase II RCT with futility design (ProMISe trial).
Not available
S-EPMC5724081 | biostudies-literature
UnknownTBK1 is associated with ALS and ALS-FTD in Sardinian patients.
Not available
S-EPMC8961272 | biostudies-literature
UnknownHFE p.H63D polymorphism does not influence ALS phenotype and survival.
Not available
S-EPMC5183653 | biostudies-literature
UnknownRandomized, double-blind, placebo-controlled trial of rapamycin in amyotrophic lateral sclerosis.
Not available
S-EPMC10435464 | biostudies-literature
UnknownShared polygenic risk and causal inferences in amyotrophic lateral sclerosis.
Not available
S-EPMC6450729 | biostudies-literature
Sort   by:  
 Page size